Literature DB >> 25234387

Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study.

D Ramírez-Prado1, A Palazón-Bru, D M Folgado-de-la Rosa, M Á Carbonell-Torregrosa, A M Martínez-Díaz, V F Gil-Guillén.   

Abstract

BACKGROUND: Many authors have analysed premature mortality in cohorts of type 2 diabetic patients, but no analyses have assessed mortality in hospitalised diabetic patients. AIM: To construct predictive models to estimate the likelihood of all-cause mortality and cardiovascular mortality in type 2 diabetic inpatients.
DESIGN: Cohort study with follow-up from 2010 to 2014.
METHODS: We evaluated mortality in a randomly selected cohort of 112 type 2 diabetic inpatients at the Hospital of Elda (Spain) in 2010-2012. OUTCOMES: all-cause mortality and cardiovascular mortality during the follow-up. Other variables: gender, age, depression, asthma/chronic obstructive pulmonary disease, hypertension, dyslipidemia, insulin, pills, smoking, walking, baseline blood glucose and creatinine. Predictive tables with risk groups were constructed to estimate the likelihood of all-cause mortality and cardiovascular mortality. Calculations were made of the area under the ROC curve (AUC).
RESULTS: During the follow-up, 52 inpatients died (46.4%, 95% CI, confidence interval: 37.2-55.7%), 22 because of cardiovascular causes (19.6%, 95% CI: 12.3-27.0%). The mean follow-up time was 2.7 ± 1.5 years. The AUC for the all-cause mortality model was 0.84 (95% CI: 0.77-0.92, p < 0.001). Associated parameters: pills, smoking, walking, gender, insulin and age. The AUC for the cardiovascular mortality model was 0.79 (95% CI: 0.67-0.91, p < 0.001). Associated parameters: age, pills, walking, smoking, depression and insulin.
CONCLUSIONS: This study provides tools to predict premature mortality in type 2 diabetic inpatients. However, before their general application they require joint validation by the internal medicine unit, emergency department, primary healthcare unit and endocrinology service to enable better prediction of the prognosis and more adequate decision-taking.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25234387     DOI: 10.1111/ijcp.12563

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

Review 1.  Epidemiology and Economic Burden of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in Spain: A Systematic Review.

Authors:  Esther Artime; Irene Romera; Silvia Díaz-Cerezo; Elías Delgado
Journal:  Diabetes Ther       Date:  2021-05-03       Impact factor: 2.945

2.  A four-year cardiovascular risk score for type 2 diabetic inpatients.

Authors:  Dolores Ramírez-Prado; Antonio Palazón-Bru; David Manuel Folgado-de la Rosa; María Ángeles Carbonell-Torregrosa; Ana María Martínez-Díaz; Damian Robert James Martínez-St John; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2015-06-02       Impact factor: 2.984

3.  Scoring System for Mortality in Patients Diagnosed with and Treated Surgically for Differentiated Thyroid Carcinoma with a 20-Year Follow-Up.

Authors:  David López-Bru; Antonio Palazón-Bru; David Manuel Folgado-de la Rosa; Vicente Francisco Gil-Guillén
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

4.  Six simple questions to detect malnutrition or malnutrition risk in elderly women.

Authors:  Tranquilina Gutiérrez-Gómez; Ernesto Cortés; Antonio Palazón-Bru; Isabel Peñarrieta-de Córdova; Vicente Francisco Gil-Guillén; Rosa María Ferrer-Diego
Journal:  PeerJ       Date:  2015-10-13       Impact factor: 2.984

5.  A valid model for predicting responsible nerve roots in lumbar degenerative disease with diagnostic doubt.

Authors:  Xiaochuan Li; Xuedong Bai; Yaohong Wu; Dike Ruan
Journal:  BMC Musculoskelet Disord       Date:  2016-03-15       Impact factor: 2.362

6.  Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics.

Authors:  José María Rico-Gomis; Antonio Palazón-Bru; Irene Triano-García; Luis Fabián Mahecha-García; Ana García-Monsalve; Andrés Navarro-Ruiz; Berta Villagordo-Peñalver; Jessica Jiménez-Abril; Alicia Martínez-Hortelano; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2016-07-07       Impact factor: 2.984

7.  Construction, internal validation and implementation in a mobile application of a scoring system to predict nonadherence to proton pump inhibitors.

Authors:  Emma Mares-García; Antonio Palazón-Bru; David Manuel Folgado-de la Rosa; Avelino Pereira-Expósito; Álvaro Martínez-Martín; Ernesto Cortés-Castell; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2017-06-30       Impact factor: 2.984

8.  Validity of Optical Coherence Tomography as a Diagnostic Method for Diabetic Retinopathy and Diabetic Macular Edema.

Authors:  Cesar Azrak; Manuel Vicente Baeza-Díaz; Antonio Palazón-Bru; Carmen Hernández-Martínez; Aída Navarro-Navarro; José Juan Martínez-Toldos; Vicente Francisco Gil-Guillén
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

9.  Construction and Validation of a 14-Year Cardiovascular Risk Score for Use in the General Population: The Puras-GEVA Chart.

Authors:  Luis Miguel Artigao-Ródenas; Julio Antonio Carbayo-Herencia; Antonio Palazón-Bru; Juan Antonio Divisón-Garrote; Carlos Sanchis-Domènech; Isabel Vigo-Aguiar; Vicente Francisco Gil-Guillén
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.